Scientific knowledge is scattered, siloed, and slow to search. Amass integrates across this fragmented landscape — patents, papers, regulatory filings, proprietary documents and data — and applies AI to create a structured, cross-linked, and queryable knowledge graph.
We build our own domain-specific embedding models to capture subtle scientific signals. We go beyond simple retrieval — enabling users to triangulate across multiple sources and trace the evidence behind any output. We’re not just summarizing documents — we’re helping teams reason with them.
The result: faster insight cycles, smarter pipelines, and more effective research-to-decision handoffs
Everything we design for GEMA starts with that premise and is governed by a set of non-negotiable principles.
We keep scientists and researchers at the helm. Researchers set the questions and constraints; Amass handles the grind, surfaces context, and supports decisions. The ownership of insight, process and decision making remains with you.
No black boxes. We work from a principle of radical transparency. Every insight generated and suggestion made should be explainable, cite-backed, and open.
Developed in the most concentrated life science cluster in the world
Co-Founder & CEO
Henrik has spent his career at the intersection of science, startups, and venture. He has led roles as CMO in an IPO’ed AI startup, CCO in a VC fund, and Venture Advisor with Antler.
Earlier, he founded a product and venture studio, successfully exiting IP and products to Coloplast. He started out in management consulting, advising companies like Novartis, Novo Nordisk, Alcon, and Lundbeck.
Co-Founder and CTO
Alexander has a PhD in Bioinformatics, and knowledge discovery. He was previously Head of AI/ML at Corti and Senior Data Scientist at Novo Nordisk, and has conducted research at the Novo Nordisk Foundation and the NCBI.
His academic work on tools for scientific knowledge discovery has been cited more than 13,000 times. He has also taught at the University of Copenhagen.
Behind Amass stands a board of seasoned leaders whose global perspectives and proven track records provide the governance and insight that drive our mission forward
Chairman
Founder and MD of SIRION Biotech GmbH, a Munich-based biotech firm recognized as a leader in viral vector development and cell modeling for preclinical research (sold to Revvity).
Also serves as board member at Lysomab and Hervolution.
Board member
General Partner at KOST Capital, an early-stage VC investing in food and bioeconomydriven innovation. Former Partner at blq invest, backing early-stage ventures like Ingrid, Bower and Hydda.
Board member
Partner at Giant Ventures. Former Danish Minister for Science and Higher Education and MP. Founded/built ZYB and Podio (exit to Vodafone and Citrix) and chair of Peakon and Lix.
We assembled some of the best minds from all over the business
